ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

TGTX TG Therapeutics Inc

16.01
-0.41 (-2.50%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
TG Therapeutics Inc TGTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.41 -2.50% 16.01 08:59:49
始値 安値 高値 終値 前日終値
16.75 15.96 17.00 16.19 16.42
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0120:00GLOBETG Therapeutics Provides Business Update and Reports First..
2024/5/0105:55GLOBETG Therapeutics to Host Conference Call on First Quarter..
2024/4/1820:30GLOBETG Therapeutics Announces Additional Data Presentations for..
2024/4/1820:00GLOBETG Therapeutics Awarded National Contract by the Department..
2024/4/1520:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
2024/3/0821:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
2024/3/0121:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
2024/3/0107:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2821:24EDGAR2Form 8-K - Current report
2024/2/2821:00GLOBETG Therapeutics Provides Business Update and Reports Fourth..
2024/2/2721:30GLOBETG Therapeutics Announces Issuance of Additional Patents for..
2024/2/2621:00GLOBETG Therapeutics Announces European Launch of BRIUMVI®..
2024/2/2321:30GLOBETG Therapeutics to Host Conference Call on Fourth Quarter..
2024/2/2021:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
2024/2/1511:53EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
2024/2/1505:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2706:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1021:37EDGAR2Form 8-K - Current report
2024/1/1021:00GLOBETG Therapeutics Provides Preliminary Fourth Quarter and Full..
2024/1/0923:20APSBiotech Massively Bid Up Before Opening Bell
2024/1/0921:00GLOBETG Therapeutics Announces Global License Agreement with..
2024/1/0908:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0908:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0607:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0601:02EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0521:30GLOBETG Therapeutics to Participate in the 42nd Annual J.P...
2024/1/0406:46EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2721:30GLOBETG Therapeutics to Participate in the 6th Annual Evercore..
2023/11/0707:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0320:30GLOBETG Therapeutics to Participate in the 5th Annual Guggenheim..
2023/11/0120:33EDGAR2Form 8-K - Current report
2023/11/0120:30GLOBETG Therapeutics Provides Business Update and Reports Third..
2023/10/3020:30GLOBETG Therapeutics to Host Conference Call on Third Quarter..
2023/10/1300:00GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
2023/10/1123:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
2023/10/0220:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
2023/9/3006:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2220:30GLOBETG Therapeutics to Participate in the 2023 Cantor Global..
2023/9/0720:30GLOBETG Therapeutics to Participate in the H.C. Wainwright 25th..
2023/8/1422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0505:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0120:29EDGAR2Form 8-K - Current report
2023/8/0120:15GLOBETG Therapeutics Provides Business Update and Reports Second..
2023/8/0120:00GLOBETG Therapeutics and Neuraxpharm Announce Ex-US..
2023/7/3121:30GLOBETG Therapeutics to Host Conference Call on Second Quarter..
2023/6/0520:30GLOBETG Therapeutics to Participate in the 2023 Jefferies..
2023/6/0222:15GLOBETG Therapeutics Announces Presentation of Data from the..
2023/6/0122:15GLOBETG Therapeutics Announces European Commission Approval for..
2023/5/3120:30GLOBETG Therapeutics Announces Data from the ULTIMATE I & II..

最近閲覧した銘柄

Delayed Upgrade Clock